IPS ACADEMIA JAPAN
iPS Academia Japan is focused on licensing businesses based on iPS cell research. The company was founded in June 2008 and is based in Mikuruba.
IPS ACADEMIA JAPAN
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2008-06-25
Address:
Mikuruba, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.ips-cell.net
Total Employee:
1+
Status:
Active
Contact:
075-754-0625
Total Funding:
1.42 B JPY
Technology used in webpage:
SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Apache Global Site Tag US Privacy User Signal Mechanism DigiCert SSL
Similar Organizations
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2012-10-19 | Healios | iPS Academia Japan investment in Corporate Round - Healios | 17 M JPY |
Newest Events participated
Participated in BIO-Europe 2017 | November 6–8 in Berlin, Germany
on 2017-11-06 as exhibitor
Official Site Inspections
http://www.ips-cell.net
- Host name: ips-cell.net
- IP address: 60.43.238.191
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "iPS Academia Japan"
About Us | iPS Academia Japan, Inc.
IPS Academia Japan, Inc. was founded on June 25, 2008, with the primary objective of facilitating the transfer of technology to industry for the practical application of iPS cell-related technologies. As the technology licensing …See details»
Company Profile / Our History | iPS Academia Japan, Inc. - ips …
ⓒCenter for iPS Cell Research and Application,Kyoto University: after the foundation; 2008: iPS Academia Japan established iPS Academia Japan, Inc. was established in Kyoto on June 25, …See details»
About iPS Academia Japan
We will give back our iPS cell research results to the community and contribute quickly and steadily to human health and welfare. We vow to continue our pursuit of this mission for as …See details»
iPS Academia Japan - Crunchbase Company Profile
IPS Academia Japan provides patent licenses for the commercialization of products derived from iPS cells, including those for regenerative medicine and …See details»
Asahi Kasei obtains license regarding allogenic iPS cell-derived ...
Oct 17, 2018 Established in June 2008 in partnership with Kyoto University to widely promote the use of iPS cell-related patents based on the research results by Prof. Shinya Yamanaka …See details»
iPS Academia Japan Inc - VentureRadar
"Our company was established in 2008 as a technology licensing organization specializing in the iPS cell technology. Since then, we have strengthened our patent portfolio consisting of the …See details»
iPS Academia Japan - Overview, News & Similar companies
IPS Academia Japan, Inc. (AJ) is an affiliate of Kyoto University, and its main role is to manage and utilize the patents and other intellectual pr operties held/controlled by Kyoto University and …See details»
KYOTO UNIVERSITY, iPS ACADEMIA JAPAN, AND iPIERIAN …
Kyoto University founded the Center for iPS Cell Research and Application (CiRA) as a part of the Institute for Integrated Cell-Material Sciences (iCeMS) in January 2008 to advance induced …See details»
iPS Academia Japan, Inc.
The present invention relates to agents (medicines, pharmaceutical compositions) containing compounds that has an inhibitory activity on motor neuron degeneration (e.g., amyotrophic lateral sclerosis, progressive bulbar paralysis, …See details»
Thyas Obtains Exclusive Rights to Manufacture Induced
Jan 17, 2019 iPS-AJ is an approved TLO (technology licensing organization) (since 2016) which was established in 2008 to widely promote the use of iPS cell-related patents based on the …See details»
What are iPS cells? | For the Public | CiRA | Center for iPS Cell ...
In 2014, a clinical research began to transplant iPS cell-derived retinal cells made from the patient's somatic cells into patients with age-related macular degeneration. In 2018, a clinical …See details»
iPS cells: a game changer for future medicine - PMC
1 Center for iPS Cell Research and Application(CiRA), Kyoto University, Kyoto, Japan. 2 JST CREST, Japan Science and Technology Agency, Saitama, Japan. Find articles by Haruhisa …See details»
iPS cell technologies: significance and applications to CNS ...
The history of investigations of cellular reprogramming that led to the development of iPS cells. Our generation of iPS cells in 2006 [] became possible due to three scientific lines of …See details»
Asahi Kasei expands scope of license regarding allogenic iPS cell ...
Jan 31, 2020 Established in June 2008 in partnership with Kyoto University to widely promote the use of iPS cell-related patents based on the research results by Prof. Shinya Yamanaka …See details»
Q&A - iPS Academia Japan, Inc.
Our mission is to facilitate the prompt and appropriate application of iPS cell technologies with the aim of benefiting the health and welfare of the human race as an Approved TLO (Technology …See details»
Integrated intracellular organization and its variations in human …
Jan 4, 2023 A dataset of 3D images from more than 200,000 human induced pluripotent stem cells is used to develop a framework to analyse cell shape and the location and organization of …See details»
Robust integrated intracellular organization of the human iPS cell ...
Dec 8, 2020 Despite the intimate link between cell organization and function, the principles underlying intracellular organization and the relation between organization, gene expression …See details»
iPSアカデミアジャパン株式会社
Ipsアカデミアジャパンは、ips細胞の研究成果を社会に還元し、迅速に、着実に人類の健康・福祉に貢献します。 ... ips細胞研究所（cira）、理化学研究所 バイオリソース研究センター 細 …See details»
Integrated intracellular organization and its variations in human …
Jan 4, 2023 Here we reduced this complexity by focusing on cellular organization—a key readout and driver of cell behaviour 3,4 —at the level of major cellular structures that …See details»
Harnessing human iPSC-microglia for CNS-wide delivery of
Apr 14, 2025 Widespread delivery of therapeutic proteins to the brain remains challenging. To determine whether human induced pluripotent stem cell (iPSC)-microglia (iMG) could enable …See details»